社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
patrickLai
IP属地：未知
+关注
帖子 · 36
帖子 · 36
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
patrickLai
patrickLai
·
2021-12-28
Good
Will Hey Dude Help Crocs Reach $5 Billion in Sales by 2026?<blockquote>Hey Dude会帮助Crocs到2026年销售额达到50亿美元吗？</blockquote>
Crocs made its largest acquisition to date last week when it inked a deal to acquire the privately-o
Will Hey Dude Help Crocs Reach $5 Billion in Sales by 2026?<blockquote>Hey Dude会帮助Crocs到2026年销售额达到50亿美元吗？</blockquote>
看
3,001
回复
评论
点赞
1
编组 21备份 2
分享
举报
patrickLai
patrickLai
·
2021-12-27
Big movement
Japan Joins Coordinated Oil Sales to Combat Rising Prices<blockquote>日本加入协调石油销售以对抗价格上涨</blockquote>
(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat risin
Japan Joins Coordinated Oil Sales to Combat Rising Prices<blockquote>日本加入协调石油销售以对抗价格上涨</blockquote>
看
2,156
回复
评论
点赞
3
编组 21备份 2
分享
举报
patrickLai
patrickLai
·
2021-12-25
Good
非常抱歉，此主贴已删除
看
3,251
回复
评论
点赞
3
编组 21备份 2
分享
举报
patrickLai
patrickLai
·
2021-12-24
Good
非常抱歉，此主贴已删除
看
3,208
回复
评论
点赞
3
编组 21备份 2
分享
举报
patrickLai
patrickLai
·
2021-12-22
Huat ah
非常抱歉，此主贴已删除
看
3,348
回复
1
点赞
5
编组 21备份 2
分享
举报
patrickLai
patrickLai
·
2021-12-19
Like like
Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>
The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5
Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>
看
2,017
回复
1
点赞
4
编组 21备份 2
分享
举报
patrickLai
patrickLai
·
2021-12-18
Yeah
Cerner Shares Surge On Reports Of $30 Billion Oracle Takeover Bid<blockquote>甲骨文出价300亿美元收购Cerner股价飙升</blockquote>
Cerner Corp. -Get Cerner Corporation Report shares surged Friday after the Wall Street Journal repor
Cerner Shares Surge On Reports Of $30 Billion Oracle Takeover Bid<blockquote>甲骨文出价300亿美元收购Cerner股价飙升</blockquote>
看
2,746
回复
1
点赞
5
编组 21备份 2
分享
举报
patrickLai
patrickLai
·
2021-12-15
Nice
非常抱歉，此主贴已删除
看
2,835
回复
2
点赞
6
编组 21备份 2
分享
举报
patrickLai
patrickLai
·
2021-12-12
Good
非常抱歉，此主贴已删除
看
2,905
回复
1
点赞
3
编组 21备份 2
分享
举报
patrickLai
patrickLai
·
2021-12-11
[Grin]
非常抱歉，此主贴已删除
看
2,697
回复
评论
点赞
3
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3585604372962377","uuid":"3585604372962377","gmtCreate":1622512789390,"gmtModify":1638170490735,"name":"patrickLai","pinyin":"patricklai","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":10,"tweetSize":36,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.02","exceedPercentage":"80.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":696601923,"gmtCreate":1640674012432,"gmtModify":1640674012552,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696601923","repostId":"1120855192","repostType":4,"repost":{"id":"1120855192","kind":"news","pubTimestamp":1640668339,"share":"https://www.laohu8.com/m/news/1120855192?lang=zh_CN&edition=full","pubTime":"2021-12-28 13:12","market":"us","language":"en","title":"Will Hey Dude Help Crocs Reach $5 Billion in Sales by 2026?<blockquote>Hey Dude会帮助Crocs到2026年销售额达到50亿美元吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1120855192","media":"Footwear News","summary":"Crocs made its largest acquisition to date last week when it inked a deal to acquire the privately-o","content":"<p>Crocs made its largest acquisition to date last week when it inked a deal to acquire the privately-owned footwear brand Hey Dude.</p><p><blockquote>Crocs上周签署了收购私营鞋类品牌Hey Dude的协议，完成了迄今为止最大的收购。</blockquote></p><p> The deal is valued at $2.5 billion and expected to close in Q1 of 2022. While Hey Dude is privately owned, Crocs pointed out the company’s impressive growth in revenue and profits in recent years. 43% of Hey Dude’s sales are currently online and the brand projects $570 million in revenue in 2021.</p><p><blockquote>该交易价值25亿美元，预计将于2022年第一季度完成。虽然Hey Dude是私营企业，但Crocs指出该公司近年来收入和利润的增长令人印象深刻。Hey Dude目前43%的销售额是在网上进行的，该品牌预计2021年收入将达到5.7亿美元。</blockquote></p><p> Crocs is confident that Hey Dude will help contribute to its recent revenue growth and align with its previously stated goal to help Crocs achieve$5 billion in sales by 2026.Crocs plans to make Hey Dude a $1 billion brand by 2024.</p><p><blockquote>Crocs相信Hey Dude将有助于为其最近的收入增长做出贡献，并与其之前制定的目标保持一致，即帮助Crocs到2026年实现50亿美元的销售额。Crocs计划到2024年使Hey Dude成为一个价值10亿美元的品牌。</blockquote></p><p> While executives seemed confident in achieving these goals, investors initially appeared more hesitant. In the wake of the announcement on Thursday, shares of Crocs dropped close to 12%, suggesting concern and uneasiness.</p><p><blockquote>尽管高管们似乎对实现这些目标充满信心，但投资者最初似乎更加犹豫。周四宣布这一消息后，Crocs股价下跌近12%，引发担忧和不安。</blockquote></p><p> However, some analysts eased investor fear and projected strong results from the acquisition.</p><p><blockquote>然而，一些分析师缓解了投资者的担忧，并预计此次收购将带来强劲的业绩。</blockquote></p><p> Williams Trading analyst Sam Poser said in a recent note that despite the reactive stock drop, the deal “will prove very accretive” to Crocs. He attributed the initial stock drop to a general investor unawareness for the Hey Dude Brand, which he said has grown revenue at a 20% rate over the last few years and is still gaining momentum.</p><p><blockquote>Williams Trading分析师Sam Poser在最近的一份报告中表示，尽管股价出现反应性下跌，但这笔交易“将证明对Crocs非常有利”。他将最初的股价下跌归因于投资者对Hey Dude品牌的普遍无知，他表示该品牌的收入在过去几年中以20%的速度增长，并且仍在增长势头。</blockquote></p><p> “Retailers are more knowledgeable of trends than the very large majority of the investment community is,” Poser wrote. “Crocs trends remain strong, and management remains confident that sales will reach $5 billion by 2026.”</p><p><blockquote>波瑟写道：“零售商比大多数投资界更了解趋势。”“Crocs的趋势依然强劲，管理层仍然有信心到2026年销售额将达到50亿美元。”</blockquote></p><p> Baird analyst Jonathan Komp also pointed out Hey Dude’s trajectory of rapid growth, highlighting how the company is estimated to have grown revenue twofold in 2021, despite supply chain issues. The brand is projected to hit $700 to $750 million in revenue in 2022.</p><p><blockquote>Baird分析师Jonathan Komp还指出了Hey Dude的快速增长轨迹，强调了尽管存在供应链问题，但该公司预计2021年收入仍将增长两倍。该品牌预计2022年收入将达到7亿至7.5亿美元。</blockquote></p><p> Crocs acquired Jibbitz, the company that makes accessories for the clogs, in 2006. Its most recent acquisition initiates the company’s transition from single-brand to multi-brand.Once under the Crocs banner, Hey Dude will still operate independently with Hey Dude founder Alessandro Rosano as strategic advisor and creative director. Former CCM Hockey CEO Rick Blackshaw has been tapped as Hey Dude’s new EVP and brand president.</p><p><blockquote>Crocs于2006年收购了生产木屐配件的Jibbitz公司。其最近的收购启动了该公司从单一品牌向多品牌的转型。一旦加入Crocs旗下，Hey Dude仍将独立运营，Hey Dude创始人Alessandro Rosano担任战略顾问和创意总监。前CCM曲棍球首席执行官里克·布莱克肖被任命为嘿伙计的新执行副总裁和品牌总裁。</blockquote></p><p> “In upcoming quarters, we are optimistic that Crocs can prove continued strong execution as the company has as a mono-brand operator, which should reinforce investor confidence in the growth outlook and support higher valuation over time,” Komp wrote.</p><p><blockquote>Komp写道：“在未来几个季度，我们乐观地认为Crocs能够像该公司作为单一品牌运营商一样继续表现出强劲的执行力，这应该会增强投资者对增长前景的信心，并随着时间的推移支持更高的估值。”</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Hey Dude Help Crocs Reach $5 Billion in Sales by 2026?<blockquote>Hey Dude会帮助Crocs到2026年销售额达到50亿美元吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Hey Dude Help Crocs Reach $5 Billion in Sales by 2026?<blockquote>Hey Dude会帮助Crocs到2026年销售额达到50亿美元吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Footwear News</strong><span class=\"h-time small\">2021-12-28 13:12</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Crocs made its largest acquisition to date last week when it inked a deal to acquire the privately-owned footwear brand Hey Dude.</p><p><blockquote>Crocs上周签署了收购私营鞋类品牌Hey Dude的协议，完成了迄今为止最大的收购。</blockquote></p><p> The deal is valued at $2.5 billion and expected to close in Q1 of 2022. While Hey Dude is privately owned, Crocs pointed out the company’s impressive growth in revenue and profits in recent years. 43% of Hey Dude’s sales are currently online and the brand projects $570 million in revenue in 2021.</p><p><blockquote>该交易价值25亿美元，预计将于2022年第一季度完成。虽然Hey Dude是私营企业，但Crocs指出该公司近年来收入和利润的增长令人印象深刻。Hey Dude目前43%的销售额是在网上进行的，该品牌预计2021年收入将达到5.7亿美元。</blockquote></p><p> Crocs is confident that Hey Dude will help contribute to its recent revenue growth and align with its previously stated goal to help Crocs achieve$5 billion in sales by 2026.Crocs plans to make Hey Dude a $1 billion brand by 2024.</p><p><blockquote>Crocs相信Hey Dude将有助于为其最近的收入增长做出贡献，并与其之前制定的目标保持一致，即帮助Crocs到2026年实现50亿美元的销售额。Crocs计划到2024年使Hey Dude成为一个价值10亿美元的品牌。</blockquote></p><p> While executives seemed confident in achieving these goals, investors initially appeared more hesitant. In the wake of the announcement on Thursday, shares of Crocs dropped close to 12%, suggesting concern and uneasiness.</p><p><blockquote>尽管高管们似乎对实现这些目标充满信心，但投资者最初似乎更加犹豫。周四宣布这一消息后，Crocs股价下跌近12%，引发担忧和不安。</blockquote></p><p> However, some analysts eased investor fear and projected strong results from the acquisition.</p><p><blockquote>然而，一些分析师缓解了投资者的担忧，并预计此次收购将带来强劲的业绩。</blockquote></p><p> Williams Trading analyst Sam Poser said in a recent note that despite the reactive stock drop, the deal “will prove very accretive” to Crocs. He attributed the initial stock drop to a general investor unawareness for the Hey Dude Brand, which he said has grown revenue at a 20% rate over the last few years and is still gaining momentum.</p><p><blockquote>Williams Trading分析师Sam Poser在最近的一份报告中表示，尽管股价出现反应性下跌，但这笔交易“将证明对Crocs非常有利”。他将最初的股价下跌归因于投资者对Hey Dude品牌的普遍无知，他表示该品牌的收入在过去几年中以20%的速度增长，并且仍在增长势头。</blockquote></p><p> “Retailers are more knowledgeable of trends than the very large majority of the investment community is,” Poser wrote. “Crocs trends remain strong, and management remains confident that sales will reach $5 billion by 2026.”</p><p><blockquote>波瑟写道：“零售商比大多数投资界更了解趋势。”“Crocs的趋势依然强劲，管理层仍然有信心到2026年销售额将达到50亿美元。”</blockquote></p><p> Baird analyst Jonathan Komp also pointed out Hey Dude’s trajectory of rapid growth, highlighting how the company is estimated to have grown revenue twofold in 2021, despite supply chain issues. The brand is projected to hit $700 to $750 million in revenue in 2022.</p><p><blockquote>Baird分析师Jonathan Komp还指出了Hey Dude的快速增长轨迹，强调了尽管存在供应链问题，但该公司预计2021年收入仍将增长两倍。该品牌预计2022年收入将达到7亿至7.5亿美元。</blockquote></p><p> Crocs acquired Jibbitz, the company that makes accessories for the clogs, in 2006. Its most recent acquisition initiates the company’s transition from single-brand to multi-brand.Once under the Crocs banner, Hey Dude will still operate independently with Hey Dude founder Alessandro Rosano as strategic advisor and creative director. Former CCM Hockey CEO Rick Blackshaw has been tapped as Hey Dude’s new EVP and brand president.</p><p><blockquote>Crocs于2006年收购了生产木屐配件的Jibbitz公司。其最近的收购启动了该公司从单一品牌向多品牌的转型。一旦加入Crocs旗下，Hey Dude仍将独立运营，Hey Dude创始人Alessandro Rosano担任战略顾问和创意总监。前CCM曲棍球首席执行官里克·布莱克肖被任命为嘿伙计的新执行副总裁和品牌总裁。</blockquote></p><p> “In upcoming quarters, we are optimistic that Crocs can prove continued strong execution as the company has as a mono-brand operator, which should reinforce investor confidence in the growth outlook and support higher valuation over time,” Komp wrote.</p><p><blockquote>Komp写道：“在未来几个季度，我们乐观地认为Crocs能够像该公司作为单一品牌运营商一样继续表现出强劲的执行力，这应该会增强投资者对增长前景的信心，并随着时间的推移支持更高的估值。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/hey-dude-help-crocs-reach-190853070.html\">Footwear News</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CROX":"卡骆驰"},"source_url":"https://finance.yahoo.com/news/hey-dude-help-crocs-reach-190853070.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120855192","content_text":"Crocs made its largest acquisition to date last week when it inked a deal to acquire the privately-owned footwear brand Hey Dude.\nThe deal is valued at $2.5 billion and expected to close in Q1 of 2022. While Hey Dude is privately owned, Crocs pointed out the company’s impressive growth in revenue and profits in recent years. 43% of Hey Dude’s sales are currently online and the brand projects $570 million in revenue in 2021.\nCrocs is confident that Hey Dude will help contribute to its recent revenue growth and align with its previously stated goal to help Crocs achieve$5 billion in sales by 2026.Crocs plans to make Hey Dude a $1 billion brand by 2024.\nWhile executives seemed confident in achieving these goals, investors initially appeared more hesitant. In the wake of the announcement on Thursday, shares of Crocs dropped close to 12%, suggesting concern and uneasiness.\nHowever, some analysts eased investor fear and projected strong results from the acquisition.\nWilliams Trading analyst Sam Poser said in a recent note that despite the reactive stock drop, the deal “will prove very accretive” to Crocs. He attributed the initial stock drop to a general investor unawareness for the Hey Dude Brand, which he said has grown revenue at a 20% rate over the last few years and is still gaining momentum.\n“Retailers are more knowledgeable of trends than the very large majority of the investment community is,” Poser wrote. “Crocs trends remain strong, and management remains confident that sales will reach $5 billion by 2026.”\nBaird analyst Jonathan Komp also pointed out Hey Dude’s trajectory of rapid growth, highlighting how the company is estimated to have grown revenue twofold in 2021, despite supply chain issues. The brand is projected to hit $700 to $750 million in revenue in 2022.\nCrocs acquired Jibbitz, the company that makes accessories for the clogs, in 2006. Its most recent acquisition initiates the company’s transition from single-brand to multi-brand.Once under the Crocs banner, Hey Dude will still operate independently with Hey Dude founder Alessandro Rosano as strategic advisor and creative director. Former CCM Hockey CEO Rick Blackshaw has been tapped as Hey Dude’s new EVP and brand president.\n“In upcoming quarters, we are optimistic that Crocs can prove continued strong execution as the company has as a mono-brand operator, which should reinforce investor confidence in the growth outlook and support higher valuation over time,” Komp wrote.","news_type":1,"symbols_score_info":{"CROX":0.9}},"isVote":1,"tweetType":1,"viewCount":3001,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696046575,"gmtCreate":1640584273394,"gmtModify":1640584273568,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"Big movement","listText":"Big movement","text":"Big movement","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696046575","repostId":"1122841396","repostType":4,"repost":{"id":"1122841396","kind":"news","pubTimestamp":1640582377,"share":"https://www.laohu8.com/m/news/1122841396?lang=zh_CN&edition=full","pubTime":"2021-12-27 13:19","market":"fut","language":"en","title":"Japan Joins Coordinated Oil Sales to Combat Rising Prices<blockquote>日本加入协调石油销售以对抗价格上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122841396","media":"Bloomberg","summary":"(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat risin","content":"<p>(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat rising prices, joining an unprecedented coordinated release of crude from strategic stockpiles that’s been led by the U.S.</p><p><blockquote>（彭博社）--日本开始出售其战略储备中的石油，以应对油价上涨，加入了由美国领导的前所未有的协调释放战略储备原油的行列。</blockquote></p><p> A government tender offered Oman crude from the strategic reserves in Shibushi for delivery between March and June, the trade ministry said in a statement. The move is part of Japan’s plans to sell oil in coordination with other consuming nations and more sales may follow, according to a ministry official, who declined to be identified because of internal policy.</p><p><blockquote>贸易部在一份声明中表示，政府招标提供来自Shibushi战略储备的阿曼原油，将于3月至6月期间交付。一位因内部政策而拒绝透露姓名的日本政府官员表示，此举是日本与其他消费国协调销售石油计划的一部分，随后可能会有更多销售。</blockquote></p><p> The Biden administration started tapping the first of its pledged 50 million barrels of reserves not long after announcing the coordinated release in late November. South Korea said last week that it will start releasing crude and oil products from its strategic reserves next month, although other countries named as part of the plan -- including China and India -- have yet to act.</p><p><blockquote>拜登政府在11月底宣布协调释放后不久，就开始动用其承诺的5000万桶储备中的第一批。韩国上周表示，将于下月开始从战略储备中释放原油和石油产品，尽管被列为该计划一部分的其他国家——包括中国和印度——尚未采取行动。</blockquote></p><p> The inaugural volume offered by Japan is 100,000 kiloliters, according to a second ministry statement. The ministry plans to announce additional sales, while monitoring the energy markets, the official said.</p><p><blockquote>根据第二份外交部声明，日本提供的初始容量为10万千升。这位官员说，该部计划宣布额外的销售，同时监控能源市场。</blockquote></p><p> At present, there are signs of weakening oil demand in Asia given the rapid spread of the omicron variant of the coronavirus. Brent crude, the global benchmark, traded slightly higher above $76 a barrel on Monday, although it’s down by about 7% since the U.S.-led plan was announced.</p><p><blockquote>目前，鉴于新冠病毒奥密克戎变种的迅速传播，亚洲石油需求有减弱的迹象。全球基准布伦特原油周一略高于每桶76美元，尽管自美国主导的计划宣布以来已下跌约7%。</blockquote></p><p> Trade Minister Koichi Hagiuda said in November that Japan would conduct the release as it replaces oil in its stockpiles. While it does that regularly, the schedule has been moved up to support similar actions elsewhere, he added.</p><p><blockquote>贸易大臣萩生田光一(Koichi Hagiuda)去年11月表示，日本将在替换库存石油时进行释放。他补充说，虽然它经常这样做，但时间表已经提前，以支持其他地方的类似行动。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan Joins Coordinated Oil Sales to Combat Rising Prices<blockquote>日本加入协调石油销售以对抗价格上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan Joins Coordinated Oil Sales to Combat Rising Prices<blockquote>日本加入协调石油销售以对抗价格上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-12-27 13:19</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat rising prices, joining an unprecedented coordinated release of crude from strategic stockpiles that’s been led by the U.S.</p><p><blockquote>（彭博社）--日本开始出售其战略储备中的石油，以应对油价上涨，加入了由美国领导的前所未有的协调释放战略储备原油的行列。</blockquote></p><p> A government tender offered Oman crude from the strategic reserves in Shibushi for delivery between March and June, the trade ministry said in a statement. The move is part of Japan’s plans to sell oil in coordination with other consuming nations and more sales may follow, according to a ministry official, who declined to be identified because of internal policy.</p><p><blockquote>贸易部在一份声明中表示，政府招标提供来自Shibushi战略储备的阿曼原油，将于3月至6月期间交付。一位因内部政策而拒绝透露姓名的日本政府官员表示，此举是日本与其他消费国协调销售石油计划的一部分，随后可能会有更多销售。</blockquote></p><p> The Biden administration started tapping the first of its pledged 50 million barrels of reserves not long after announcing the coordinated release in late November. South Korea said last week that it will start releasing crude and oil products from its strategic reserves next month, although other countries named as part of the plan -- including China and India -- have yet to act.</p><p><blockquote>拜登政府在11月底宣布协调释放后不久，就开始动用其承诺的5000万桶储备中的第一批。韩国上周表示，将于下月开始从战略储备中释放原油和石油产品，尽管被列为该计划一部分的其他国家——包括中国和印度——尚未采取行动。</blockquote></p><p> The inaugural volume offered by Japan is 100,000 kiloliters, according to a second ministry statement. The ministry plans to announce additional sales, while monitoring the energy markets, the official said.</p><p><blockquote>根据第二份外交部声明，日本提供的初始容量为10万千升。这位官员说，该部计划宣布额外的销售，同时监控能源市场。</blockquote></p><p> At present, there are signs of weakening oil demand in Asia given the rapid spread of the omicron variant of the coronavirus. Brent crude, the global benchmark, traded slightly higher above $76 a barrel on Monday, although it’s down by about 7% since the U.S.-led plan was announced.</p><p><blockquote>目前，鉴于新冠病毒奥密克戎变种的迅速传播，亚洲石油需求有减弱的迹象。全球基准布伦特原油周一略高于每桶76美元，尽管自美国主导的计划宣布以来已下跌约7%。</blockquote></p><p> Trade Minister Koichi Hagiuda said in November that Japan would conduct the release as it replaces oil in its stockpiles. While it does that regularly, the schedule has been moved up to support similar actions elsewhere, he added.</p><p><blockquote>贸易大臣萩生田光一(Koichi Hagiuda)去年11月表示，日本将在替换库存石油时进行释放。他补充说，虽然它经常这样做，但时间表已经提前，以支持其他地方的类似行动。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/japan-offers-oil-strategic-reserves-023254703.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/japan-offers-oil-strategic-reserves-023254703.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122841396","content_text":"(Bloomberg) -- Japan kicked off the sale of oil from its strategic reserves in a bid to combat rising prices, joining an unprecedented coordinated release of crude from strategic stockpiles that’s been led by the U.S.\nA government tender offered Oman crude from the strategic reserves in Shibushi for delivery between March and June, the trade ministry said in a statement. The move is part of Japan’s plans to sell oil in coordination with other consuming nations and more sales may follow, according to a ministry official, who declined to be identified because of internal policy.\nThe Biden administration started tapping the first of its pledged 50 million barrels of reserves not long after announcing the coordinated release in late November. South Korea said last week that it will start releasing crude and oil products from its strategic reserves next month, although other countries named as part of the plan -- including China and India -- have yet to act.\nThe inaugural volume offered by Japan is 100,000 kiloliters, according to a second ministry statement. The ministry plans to announce additional sales, while monitoring the energy markets, the official said.\nAt present, there are signs of weakening oil demand in Asia given the rapid spread of the omicron variant of the coronavirus. Brent crude, the global benchmark, traded slightly higher above $76 a barrel on Monday, although it’s down by about 7% since the U.S.-led plan was announced.\nTrade Minister Koichi Hagiuda said in November that Japan would conduct the release as it replaces oil in its stockpiles. While it does that regularly, the schedule has been moved up to support similar actions elsewhere, he added.","news_type":1,"symbols_score_info":{"CLmain":0.9,"BZmain":0.9}},"isVote":1,"tweetType":1,"viewCount":2156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698257535,"gmtCreate":1640419284637,"gmtModify":1640419284792,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698257535","repostId":"2193917819","repostType":4,"isVote":1,"tweetType":1,"viewCount":3251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698143823,"gmtCreate":1640326004272,"gmtModify":1640326004425,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698143823","repostId":"1105843279","repostType":4,"isVote":1,"tweetType":1,"viewCount":3208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691165420,"gmtCreate":1640151523703,"gmtModify":1640151523844,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"Huat ah","listText":"Huat ah","text":"Huat ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691165420","repostId":"1130693665","repostType":4,"isVote":1,"tweetType":1,"viewCount":3348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693093938,"gmtCreate":1639921078798,"gmtModify":1639921078935,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"Like like","listText":"Like like","text":"Like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693093938","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://www.laohu8.com/m/news/1122414343?lang=zh_CN&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块，涨幅约为2.5%，主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨，而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中，<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司，溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势，本周上涨约20.7%，有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗，股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时，这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后，该公司每周上涨约25.2%，使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时，Vir Biotechnology（纳斯达克股票代码：VIR）飙升约23.7%，成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克（纽约证券交易所股票代码：GSK）合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有，<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家：<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻，再次提高了COVID-19疫苗的销售指引，因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势，<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%，创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中，两家新IPO的生物技术公司Instil Bio（纳斯达克股票代码：TIL）和Exscientia（纳斯达克股票代码：EXAI）脱颖而出，尽管它们在华尔街获得了良好的评级，但分别下跌了19.3%和约13.5%。与此同时，处方药比价平台运营商GoodRx Holdings（纳斯达克股票代码：GDRX）股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的，<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>，暴跌约13.1%，受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics（纳斯达克股票代码：ALLO）在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋，其中包括Cathie Wood的Ark Investment Management，该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-19 11:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块，涨幅约为2.5%，主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨，而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中，<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司，溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势，本周上涨约20.7%，有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗，股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时，这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后，该公司每周上涨约25.2%，使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时，Vir Biotechnology（纳斯达克股票代码：VIR）飙升约23.7%，成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克（纽约证券交易所股票代码：GSK）合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有，<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家：<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻，再次提高了COVID-19疫苗的销售指引，因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势，<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%，创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中，两家新IPO的生物技术公司Instil Bio（纳斯达克股票代码：TIL）和Exscientia（纳斯达克股票代码：EXAI）脱颖而出，尽管它们在华尔街获得了良好的评级，但分别下跌了19.3%和约13.5%。与此同时，处方药比价平台运营商GoodRx Holdings（纳斯达克股票代码：GDRX）股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的，<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>，暴跌约13.1%，受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics（纳斯达克股票代码：ALLO）在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋，其中包括Cathie Wood的Ark Investment Management，该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4568":"美国抗疫概念","ORCL":"甲骨文","ARNA":"阿里那","CERN":"美国塞纳"},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals dominated with a ~83.8% rise after Pfizer agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle for the electronic-medical-records company.\nVaccine developer, Novavax jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1,"symbols_score_info":{"ORCL":0.9,"PFE":0.9,"CERN":0.9,"ARNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2017,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699282422,"gmtCreate":1639811267512,"gmtModify":1639811267624,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"Yeah","listText":"Yeah","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699282422","repostId":"1106862392","repostType":4,"repost":{"id":"1106862392","kind":"news","pubTimestamp":1639810154,"share":"https://www.laohu8.com/m/news/1106862392?lang=zh_CN&edition=full","pubTime":"2021-12-18 14:49","market":"us","language":"en","title":"Cerner Shares Surge On Reports Of $30 Billion Oracle Takeover Bid<blockquote>甲骨文出价300亿美元收购Cerner股价飙升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1106862392","media":"The Street","summary":"Cerner Corp. -Get Cerner Corporation Report shares surged Friday after the Wall Street Journal repor","content":"<p><a href=\"https://laohu8.com/S/CERN\">Cerner Corp.</a> -Get Cerner Corporation Report shares surged Friday after the Wall Street Journal reported that <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> -Get Oracle Corporation Report is preparing to buy the electronic medical records company in a deal worth as much as $30 billion.</p><p><blockquote><a href=\"https://laohu8.com/S/CERN\">塞尔纳公司。</a>-获取Cerner Corporation报告《华尔街日报》报道后，股价周五飙升<a href=\"https://laohu8.com/S/ORCL\">神谕</a>-获取甲骨文公司报告称，该公司正准备以高达300亿美元的交易收购这家电子病历公司。</blockquote></p><p> A takeover of Cerner, the biggest designer of software used by doctors and hospitals to mange and store medical records, would not only be one of the biggest M&A deals of the year, it would also be the biggest in Oracle's corporate history -- more than 3 times the size of its $10 billion purchase of PeopleSoft in 2005 -- and a bold statement from CEO Safra Catz, who assumed sole control of the cloud and software group in 2019.</p><p><blockquote>收购Cerner（医生和医院用于管理和存储医疗记录的软件的最大设计者）不仅将是今年最大的并购交易之一，也将是甲骨文公司历史上最大的一笔交易——超过其2005年斥资100亿美元收购PeopleSoft规模的3倍，首席执行官萨夫拉·卡茨(Safra Catz)也发表了大胆声明，他于2019年接管了该云和软件集团的唯一控制权。</blockquote></p><p> Cerner, which posted third quarter revenues of $1.468 billion in October, has a 25% share of the medical records market, according to SVB Leerrink.</p><p><blockquote>根据SVB Leerrink的数据，Cerner 10月份公布的第三季度收入为14.68亿美元，占据医疗记录市场25%的份额。</blockquote></p><p> \"We view the potential deal as a positive for CERN as it will allow the company to undergo its transition from an EHR to a healthcare platform within the cover of a far larger organization, and with the benefit of a premium takeout valuation,\" said Leerink analysts Stephanie Davis. \"We are cautious on potential pushback from Oracle shareholders creating risk to a deal announcement, as the deal would mark a transition away from the company’s core organic growth acceleration story while the check size implies likely dilution to holders.\"</p><p><blockquote>Leerink表示：“我们认为这笔潜在交易对CERN来说是积极的，因为它将使该公司能够在一个更大的组织的保护下从EHR过渡到医疗保健平台，并受益于溢价外卖估值。”分析师斯蒂芬妮·戴维斯。“我们对甲骨文股东的潜在抵制给交易公告带来风险持谨慎态度，因为该交易将标志着该公司核心有机增长加速故事的转变，而支票规模意味着持有人可能会被稀释。”</blockquote></p><p> Cerner shares ended up $10.28, or 12.9%, at $89.77. Oracle shares fell $6.60, or, 6.4%, to $96.62.</p><p><blockquote>Cerner股价收盘上涨10.28美元，涨幅12.9%，至89.77美元。甲骨文股价下跌6.60美元，跌幅6.4%，至96.62美元。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/22804ede647ca4b70ab697475b6acc79\" tg-width=\"966\" tg-height=\"636\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Oracle shares traded at an all-time high last week, giving the cloud and software group a market value of around $290 billion, following better-than-expected second quarter earnings and a robust near-term outlook.</p><p><blockquote>甲骨文股价上周创下历史新高，这家云和软件集团的市值约为2900亿美元，此前第二季度盈利好于预期，近期前景强劲。</blockquote></p><p> Oracle, which earns the bulk of its revenues from its cloud services and license support unit, beat Street earnings forecasts by a dime with an adjusted second quarter bottom line of $1.12 per share.</p><p><blockquote>甲骨文的大部分收入来自其云服务和许可证支持部门，调整后的第二季度净利润为每股1.12美元，超出了华尔街的盈利预期。</blockquote></p><p> Cloud division revenues topped $7.5 billion as companies continue to spend on hybrid work solutions in a post-pandemic world, while overall revenues grew by 6% to $10.4 billon.</p><p><blockquote>随着公司在大流行后的世界中继续在混合工作解决方案上投入资金，云部门的收入突破了75亿美元，而总收入增长了6%，达到104亿美元。</blockquote></p><p> Bookings grew at an even faster pace, rising 11% from last year's levels, giving Oracle the confidence to forecast current quarter revenues in the region of $10.7 billion to $10.9 billion, based on growth forecasts, with profits of between $1.19 and $1.23 per share.</p><p><blockquote>预订量增长速度更快，比去年增长11%，这让甲骨文有信心根据增长预测预测本季度收入在107亿美元至109亿美元之间，每股利润在1.19美元至1.23美元之间。</blockquote></p><p></p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cerner Shares Surge On Reports Of $30 Billion Oracle Takeover Bid<blockquote>甲骨文出价300亿美元收购Cerner股价飙升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCerner Shares Surge On Reports Of $30 Billion Oracle Takeover Bid<blockquote>甲骨文出价300亿美元收购Cerner股价飙升</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Street</strong><span class=\"h-time small\">2021-12-18 14:49</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/CERN\">Cerner Corp.</a> -Get Cerner Corporation Report shares surged Friday after the Wall Street Journal reported that <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> -Get Oracle Corporation Report is preparing to buy the electronic medical records company in a deal worth as much as $30 billion.</p><p><blockquote><a href=\"https://laohu8.com/S/CERN\">塞尔纳公司。</a>-获取Cerner Corporation报告《华尔街日报》报道后，股价周五飙升<a href=\"https://laohu8.com/S/ORCL\">神谕</a>-获取甲骨文公司报告称，该公司正准备以高达300亿美元的交易收购这家电子病历公司。</blockquote></p><p> A takeover of Cerner, the biggest designer of software used by doctors and hospitals to mange and store medical records, would not only be one of the biggest M&A deals of the year, it would also be the biggest in Oracle's corporate history -- more than 3 times the size of its $10 billion purchase of PeopleSoft in 2005 -- and a bold statement from CEO Safra Catz, who assumed sole control of the cloud and software group in 2019.</p><p><blockquote>收购Cerner（医生和医院用于管理和存储医疗记录的软件的最大设计者）不仅将是今年最大的并购交易之一，也将是甲骨文公司历史上最大的一笔交易——超过其2005年斥资100亿美元收购PeopleSoft规模的3倍，首席执行官萨夫拉·卡茨(Safra Catz)也发表了大胆声明，他于2019年接管了该云和软件集团的唯一控制权。</blockquote></p><p> Cerner, which posted third quarter revenues of $1.468 billion in October, has a 25% share of the medical records market, according to SVB Leerrink.</p><p><blockquote>根据SVB Leerrink的数据，Cerner 10月份公布的第三季度收入为14.68亿美元，占据医疗记录市场25%的份额。</blockquote></p><p> \"We view the potential deal as a positive for CERN as it will allow the company to undergo its transition from an EHR to a healthcare platform within the cover of a far larger organization, and with the benefit of a premium takeout valuation,\" said Leerink analysts Stephanie Davis. \"We are cautious on potential pushback from Oracle shareholders creating risk to a deal announcement, as the deal would mark a transition away from the company’s core organic growth acceleration story while the check size implies likely dilution to holders.\"</p><p><blockquote>Leerink表示：“我们认为这笔潜在交易对CERN来说是积极的，因为它将使该公司能够在一个更大的组织的保护下从EHR过渡到医疗保健平台，并受益于溢价外卖估值。”分析师斯蒂芬妮·戴维斯。“我们对甲骨文股东的潜在抵制给交易公告带来风险持谨慎态度，因为该交易将标志着该公司核心有机增长加速故事的转变，而支票规模意味着持有人可能会被稀释。”</blockquote></p><p> Cerner shares ended up $10.28, or 12.9%, at $89.77. Oracle shares fell $6.60, or, 6.4%, to $96.62.</p><p><blockquote>Cerner股价收盘上涨10.28美元，涨幅12.9%，至89.77美元。甲骨文股价下跌6.60美元，跌幅6.4%，至96.62美元。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/22804ede647ca4b70ab697475b6acc79\" tg-width=\"966\" tg-height=\"636\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Oracle shares traded at an all-time high last week, giving the cloud and software group a market value of around $290 billion, following better-than-expected second quarter earnings and a robust near-term outlook.</p><p><blockquote>甲骨文股价上周创下历史新高，这家云和软件集团的市值约为2900亿美元，此前第二季度盈利好于预期，近期前景强劲。</blockquote></p><p> Oracle, which earns the bulk of its revenues from its cloud services and license support unit, beat Street earnings forecasts by a dime with an adjusted second quarter bottom line of $1.12 per share.</p><p><blockquote>甲骨文的大部分收入来自其云服务和许可证支持部门，调整后的第二季度净利润为每股1.12美元，超出了华尔街的盈利预期。</blockquote></p><p> Cloud division revenues topped $7.5 billion as companies continue to spend on hybrid work solutions in a post-pandemic world, while overall revenues grew by 6% to $10.4 billon.</p><p><blockquote>随着公司在大流行后的世界中继续在混合工作解决方案上投入资金，云部门的收入突破了75亿美元，而总收入增长了6%，达到104亿美元。</blockquote></p><p> Bookings grew at an even faster pace, rising 11% from last year's levels, giving Oracle the confidence to forecast current quarter revenues in the region of $10.7 billion to $10.9 billion, based on growth forecasts, with profits of between $1.19 and $1.23 per share.</p><p><blockquote>预订量增长速度更快，比去年增长11%，这让甲骨文有信心根据增长预测预测本季度收入在107亿美元至109亿美元之间，每股利润在1.19美元至1.23美元之间。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/markets/cerner-shares-surge-on-reports-of-30-billion-oracle-takeover-bid\">The Street</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CERN":"美国塞纳","ORCL":"甲骨文"},"source_url":"https://www.thestreet.com/markets/cerner-shares-surge-on-reports-of-30-billion-oracle-takeover-bid","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106862392","content_text":"Cerner Corp. -Get Cerner Corporation Report shares surged Friday after the Wall Street Journal reported that Oracle -Get Oracle Corporation Report is preparing to buy the electronic medical records company in a deal worth as much as $30 billion.\nA takeover of Cerner, the biggest designer of software used by doctors and hospitals to mange and store medical records, would not only be one of the biggest M&A deals of the year, it would also be the biggest in Oracle's corporate history -- more than 3 times the size of its $10 billion purchase of PeopleSoft in 2005 -- and a bold statement from CEO Safra Catz, who assumed sole control of the cloud and software group in 2019.\nCerner, which posted third quarter revenues of $1.468 billion in October, has a 25% share of the medical records market, according to SVB Leerrink.\n\"We view the potential deal as a positive for CERN as it will allow the company to undergo its transition from an EHR to a healthcare platform within the cover of a far larger organization, and with the benefit of a premium takeout valuation,\" said Leerink analysts Stephanie Davis. \"We are cautious on potential pushback from Oracle shareholders creating risk to a deal announcement, as the deal would mark a transition away from the company’s core organic growth acceleration story while the check size implies likely dilution to holders.\"\nCerner shares ended up $10.28, or 12.9%, at $89.77. Oracle shares fell $6.60, or, 6.4%, to $96.62.\n\nOracle shares traded at an all-time high last week, giving the cloud and software group a market value of around $290 billion, following better-than-expected second quarter earnings and a robust near-term outlook.\nOracle, which earns the bulk of its revenues from its cloud services and license support unit, beat Street earnings forecasts by a dime with an adjusted second quarter bottom line of $1.12 per share.\nCloud division revenues topped $7.5 billion as companies continue to spend on hybrid work solutions in a post-pandemic world, while overall revenues grew by 6% to $10.4 billon.\nBookings grew at an even faster pace, rising 11% from last year's levels, giving Oracle the confidence to forecast current quarter revenues in the region of $10.7 billion to $10.9 billion, based on growth forecasts, with profits of between $1.19 and $1.23 per share.","news_type":1,"symbols_score_info":{"ORCL":0.9,"CERN":0.9}},"isVote":1,"tweetType":1,"viewCount":2746,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607688637,"gmtCreate":1639532977052,"gmtModify":1639533012079,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607688637","repostId":"2191602753","repostType":4,"isVote":1,"tweetType":1,"viewCount":2835,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604088394,"gmtCreate":1639281362231,"gmtModify":1639281362356,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604088394","repostId":"2190567199","repostType":4,"isVote":1,"tweetType":1,"viewCount":2905,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605513574,"gmtCreate":1639189549315,"gmtModify":1639190159144,"author":{"id":"3585604372962377","authorId":"3585604372962377","name":"patrickLai","avatar":"https://static.tigerbbs.com/baedd77ad7c3a28da1ae2ecc8b2e88aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585604372962377","idStr":"3585604372962377"},"themes":[],"htmlText":"[Grin] ","listText":"[Grin] ","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605513574","repostId":"2190673267","repostType":4,"isVote":1,"tweetType":1,"viewCount":2697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}